Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence

Gower MN, Ratner LR, Williams AK, Rossi JS, Stouffer GA, Lee CR

Pharmacogenomics and Personalized Medicine 2020, 13:239-252

Published Date: 27 July 2020